News Medical on MSN
SwRI-developed single-use 3D-printed bioreactor harvests induced Pluripotent Stem Cells
Southwest Research Institute (SwRI) has demonstrated a new application for its cell-expansion bioreactor to advance tissue engineering and cell-based therapies for treatment of injuries and diseases.
A research team in South Korea has successfully developed a novel technology that combines nanoparticles with stem cells to ...
Explore Clecell and CLE-iFTs, innovations in bioprinted skin technology using human induced pluripotent stem cells for better ...
News-Medical.Net on MSN
Study reveals how melanoma evolves to resist immunotherapy
A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators reveals how melanoma, the deadliest form of skin ...
The global healthcare industry has long chased the same paradox: longer life, shorter vitality. Over the past century, ...
Waymo may have a school-bus problem, and more details about BYD's plans for Japan.
Pushing the limits of electric vehicle performance, Toyota will debut its first-ever battery-electric SEMA concept build with the bZ Time Attack Concept at the 2025 SEMA Show—a purpose-built, BEV ...
Scientists at the University of Osaka have developed a novel hydrogel that enables the efficient, three-dimensional (3D) ...
Researchers at the University of California San Diego School of Medicine have developed a new approach for identifying ...
A collaborative research group has developed a novel therapeutic candidate that may improve the prognosis of severe cutaneous adverse reactions such as Stevens–Johnson syndrome (SJS) and toxic ...
The transcription factor HEB synergizes with TCR signaling to upregulate Id3, which is required for the maturation of fetal IL-17-producing γδ T cells.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results